Immutep Ltd has released a press release.
Immutep granted European patent for IMP761
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Immutep
- Immutep reports improving results from INSIGHT-004 trial
- IMM & Monash Uni receive funding grant for LAG-3 Research
- Appendix 4E & 2020 Full Year Statutory Accounts
- Recruitment of stage 1 of part B in TACTI-002 study complete
- Immutep granted US patent for eftilagimod alpha
Later from Immutep
- COVID-19 phase 2 investigator initiated trial commences
- 2020 AGM Presentation
- Immutep enters into a Licence & Collaboration with LabCorp
- Immutep Announces Australian Patent Grant for IMP701
- Encouraging Phase II TACTI-002 data reported at SITC 2020
Follow Immutep into a list and get an email when it puts out news.
Follow Immutep